Clinical findings, outcome and treatment in patients ≥ 75 years with acute myocardial infarction

European Journal of Epidemiology

Volumn 18, Issue 8, 2003, Pages 781-786

  Kotamäki, Mervi ^a   Strandberg, Timo E ^b   Nieminen, Markku S ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Acute myocardial infarction; Elderly; Infection

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATINE KINASE MB; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART INFARCTION; HEART REINFARCTION; HEART SURGERY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FINLAND; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PNEUMONIA; REGISTRIES; RISK FACTORS; SEX FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0042928287     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025393209660     Document Type: Article

References (19)

1. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: A 20-year population-based perspective (1975-1995). Am J Cardiol 1998; 82: 1311-1317.
2. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-1422.
3. Maynard C, Litwin PE, Martin JS, Weaver WD. Treatment and outcome of acute myocardial infarction in women 75 years of age and older: Findings from the Myocardial Infarction Triage and Intervention Registry. Cardiol Elderly 1993; 1: 121-125.
4. Smith SC Jr, Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol 1990; 16: 784-792.
5. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991; 18: 657-662.
6. Chung MK, Bosner MS, McKenzie JP, Shen J, Rich MW. Prognosis of patients ≥ 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥ 70 years of age with Q-wave acute myocardial infarction. Am J Cardiol 1995; 75: 18-22.
7. Bueno H, Vidan T, Almazan A, Lopez-Sendon JL, Delcan JL. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation 1995; 92: 1133-1140.
8. Lallukka K, Vanhanen H, Tilvis R. The prognosis and treatment of patients over 74 years of age with acute myocardial infarction in Helsinki University Central Hospital in 1981 and 1994 (in Finnish). Gerontologia 1995; 9: 268-272.
9. Paul SD, O'Gara PT, Mahjoub ZA, et al. Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions and prognosis. Am Heart J 1996; 131: 710-715.
10. Devlin W, Cragg D, Jacks M, Friedman H, O'Neill W, Grines C. Comparison of outcome in patients with acute myocardial infarction aged ≥ 75 years with that in younger patients. Am J Cardiol 1995; 75: 573-576.
11. Pietilä K, Harmoinen A, Pöyhönen L, Koskinen M, Heikkilä J, Ruosteenoja R. Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction. Br Heart J 1987; 58: 225-229.
12. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q wave acute myocardial infarction. Circulation 1997; 96: 778-784.
13. Gottlieb S, Goldbourt U, Boyko V, et al. Improved outcome of elderly patients (≥ 75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. Circulation 1997; 95: 342-350.
14. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-2246.
15. EUROASPIRE Study Group. EUROASPIRE. An European Society of Cardiology Survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 1997; 18: 1569-1582.
16. Strandberg TE, Pitkala K, Kulp S, Tilvis RS. Use of cardiovascular drugs by home-dwelling coronary patients aged 75 years and older: A population-based cross-sectional survey in Helsinki, Finland. Eur J Clin Pharmacol 2001; 57: 513-516.
17. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥ 125 mg/dl treated with statins versus no lipid-lowering drugs. Am J Cardiol 2002; 89: 67-69.
18. Heart Protection Study Collaborative Group. MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
19. Strandberg TE, Pitkala K, Berglind S, Nieminer MS, Tilvis R. Multifactorial cardiovascular disease prevention in patients aged 75 and older: A randomized controlled trial. Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study. Am Heart J 2001; 142: 945-951.